Medicamen
MEDICAMEQ.NSMedicamen Biotech Limited Price (MEDICAMEQ.NS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
12,659,277
(1.633)%Revenue and Profitability
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 769,328,000 | 863,351,000 | 1,016,107,358 | 1,229,729,414 | 1,005,269,426 | 639,978,841 | 732,486,434 | 777,938,105 | 672,759,231 | 824,557,444 | 1,115,071,923 | 1,226,044,667 | 1,255,037,635 | 1,127,160,827 | 1,154,452,362 | 1,408,674,000 | 1,793,062,000 |
| Net Income | 15,100,000 | 13,773,000 | 39,761,896 | 27,769,554 | -8,245,332 | -49,276,486 | 941,821 | 4,406,318 | 4,808,936 | 51,601,035 | 101,127,435 | 120,256,930 | 132,911,779 | 121,294,399 | 148,977,000 | 148,441,000 | 109,310,000 |
| FCF USD | - | 62,771,909 | -24,201,269 | 74,588,125 | -51,067,194 | -28,337,066 | 41,589,383 | -33,690,039 | 55,320,650 | 12,724,517 | -136,397,013 | -113,805,084 | -248,090,522 | -51,943,431 | -44,991,375 | -128,939,000 | -130,310,000 |
| OCF USD | - | 83,066,575 | 10,996,041 | 113,520,976 | -34,895,124 | -15,732,753 | 51,387,416 | -32,743,637 | 62,057,861 | 35,922,294 | -54,537,112 | 43,008,581 | 128,017,944 | 127,715,706 | 41,091,022 | -62,928,000 | -67,438,000 |
Financial Health - DEBT
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | - | 0.00 | 2.21 | 4.58 | -11.90 | -0.04 | 1.73 | 0.35 | 9.54 | 0.68 | 0.24 | 0.01 | 0.00 | 0.19 | 0.43 | 0.34 | 0.08 |
| D/E | 0.00 | 0.68 | 0.78 | 0.48 | 0.64 | 1.08 | 0.93 | 1.21 | 1.14 | 0.77 | 0.19 | 0.14 | 0.09 | 0.14 | 0.18 | 0.13 | 0.15 |
| CA/CL | - | 1.16 | 1.31 | 1.20 | 0.96 | 0.88 | 0.92 | 1.08 | 1.09 | 1.25 | 2.21 | 1.98 | 1.84 | 1.80 | 1.69 | 1.98 | 1.89 |
| TA/TL | - | 1.39 | 1.39 | 1.41 | 1.41 | 1.32 | 1.34 | 1.33 | 1.43 | 1.57 | 2.74 | 2.73 | 3.02 | 3.17 | 2.85 | 3.27 | 3.36 |
| Total Debt | - | 87,729,740 | 127,048,327 | 98,107,127 | 129,225,883 | 168,980,567 | 154,073,975 | 207,151,570 | 204,546,153 | 207,511,704 | 144,966,735 | 117,550,621 | 114,714,673 | 188,193,393 | 257,958,957 | 241,827,000 | 311,115,000 |
Management Performance
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | 0.00% | 6.21% | 13.49% | 7.21% | -2.38% | -14.39% | 0.28% | 1.07% | 1.21% | 11.24% | 11.82% | 11.60% | 9.29% | 8.13% | 8.48% | 6.90% | 15.65% |
| ROE | 0.00% | 10.63% | 24.45% | 13.60% | -4.10% | -31.35% | 0.57% | 2.56% | 2.69% | 19.27% | 13.55% | 13.88% | 10.96% | 9.13% | 10.17% | 7.67% | 5.28% |
| ROA | - | 0.00% | 8.68% | 4.81% | -1.18% | -7.15% | 0.14% | 0.68% | 0.70% | 8.60% | 13.78% | 10.23% | 9.73% | 6.69% | 7.68% | 6.53% | 3.92% |
| NM % | 1.96% | 1.60% | 3.91% | 2.26% | -0.82% | -7.70% | 0.13% | 0.57% | 0.71% | 6.26% | 9.07% | 9.81% | 10.59% | 10.76% | 12.90% | 10.54% | 6.10% |
| FCF / R% | - | 7.27% | -2.38% | 6.07% | -5.08% | -4.43% | 5.68% | -4.33% | 8.22% | 1.54% | -12.23% | -9.28% | -19.77% | -4.61% | -3.90% | -9.15% | -7.27% |
| FCF / NI% | - | 1,663.56% | -60.87% | 268.60% | 619.35% | 57.51% | 4,415.85% | -764.58% | 1,150.37% | 24.66% | -134.88% | -94.63% | -186.66% | -42.82% | -30.20% | -87.54% | -119.21% |
| Operating Margin (OM) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.07 | 0.08 | 0.07 | 0.10 | 0.16 | 0.25 | 0.39 | 0.48 | 0.49 | 0.46 |
Per Share
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 1.96 | 1.78 | 5.15 | 3.59 | -1.04 | -5.88 | 0.11 | 0.49 | 0.48 | 4.95 | 9.03 | 10.28 | 10.88 | 9.93 | 12.19 | 11.92 | 8.63 |
| SPS | 99.86 | 111.81 | 131.59 | 159.14 | 127.28 | 76.41 | 86.26 | 86.14 | 67.84 | 79.10 | 99.57 | 104.81 | 102.73 | 92.26 | 94.50 | 113.09 | 141.64 |
| OCPS | 0.00 | 10.76 | 1.42 | 14.69 | -4.42 | -1.88 | 6.05 | -3.63 | 6.26 | 3.45 | -4.87 | 3.68 | 10.48 | 10.45 | 3.36 | -5.05 | -5.33 |
| FCPS | 0.00 | 8.13 | -3.13 | 9.65 | -6.47 | -3.38 | 4.90 | -3.73 | 5.58 | 1.22 | -12.18 | -9.73 | -20.31 | -4.25 | -3.68 | -10.35 | -10.29 |
| BVPS | 0.00 | 16.78 | 21.06 | 26.42 | 25.45 | 18.77 | 19.48 | 19.03 | 18.06 | 25.69 | 66.62 | 74.06 | 99.22 | 108.78 | 119.89 | 155.28 | 163.50 |
Per Share - CAGR
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 1.96 | 1.78 | 5.15 | 3.59 | -1.04 | -5.88 | 0.11 | 0.49 | 0.48 | 4.95 | 9.03 | 10.28 | 10.88 | 9.93 | 12.19 | 11.92 | 8.63 |
| CAGR-SPS | 99.86 | 111.81 | 131.59 | 159.14 | 127.28 | 76.41 | 86.26 | 86.14 | 67.84 | 79.10 | 99.57 | 104.81 | 102.73 | 92.26 | 94.50 | 113.09 | 141.64 |
| CAGR-OCPS | 0.00 | 10.76 | 1.42 | 14.69 | -4.42 | -1.88 | 6.05 | -3.63 | 6.26 | 3.45 | -4.87 | 3.68 | 10.48 | 10.45 | 3.36 | -5.05 | -5.33 |
| CAGR-FCPS | 0.00 | 8.13 | -3.13 | 9.65 | -6.47 | -3.38 | 4.90 | -3.73 | 5.58 | 1.22 | -12.18 | -9.73 | -20.31 | -4.25 | -3.68 | -10.35 | -10.29 |
| CAGR-BVPS | 0.00 | 16.78 | 21.06 | 26.42 | 25.45 | 18.77 | 19.48 | 19.03 | 18.06 | 25.69 | 66.62 | 74.06 | 99.22 | 108.78 | 119.89 | 155.28 | 163.50 |